Rac-7-((R)-2-((1S,2S)-bi(cyclopentan)-2-ylamino)-1-hydroxyethyl)-4-hydroxybenzo[d]thiazol-2(3H)-one

ID: ALA3323653

PubChem CID: 118710935

Max Phase: Preclinical

Molecular Formula: C19H26N2O3S

Molecular Weight: 362.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1

Standard InChI:  InChI=1S/C19H26N2O3S/c22-15-9-8-13(18-17(15)21-19(24)25-18)16(23)10-20-14-7-3-6-12(14)11-4-1-2-5-11/h8-9,11-12,14,16,20,22-23H,1-7,10H2,(H,21,24)/t12-,14-,16-/m0/s1

Standard InChI Key:  LMKMYJGZBLESNG-NOLJZWGESA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.9694  -12.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9683  -13.5522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6830  -13.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6812  -12.3121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3966  -12.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3969  -13.5522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1873  -13.8088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6756  -13.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1869  -12.4642    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6788  -11.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920  -11.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9631  -11.0767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3895  -10.2474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1027   -9.8328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8586  -10.1671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4088   -9.5524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9941   -8.8390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1877   -9.0131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5006  -13.1359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6832  -14.7900    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0323  -10.9736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4836  -11.5910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8980  -12.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7046  -12.1306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7885  -11.3100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 10 12  1  1
 11 13  1  0
 14 13  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
  8 19  2  0
  3 20  1  0
 15 21  1  1
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3323653

    ---

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.50Molecular Weight (Monoisotopic): 362.1664AlogP: 3.28#Rotatable Bonds: 5
Polar Surface Area: 85.35Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 6.98CX Basic pKa: 9.94CX LogP: 2.36CX LogD: 2.27
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: 0.41

References

1. Arnold N, Beattie D, Bradley M, Brearley A, Brown L, Charlton SJ, Fairhurst RA, Farr D, Fozard J, Fullerton J, Gosling M, Hatto J, Janus D, Jones D, Jordan L, Lewis C, Maas J, McCarthy C, Mercer M, Oakman H, Press N, Profit R, Schuerch F, Sykes D, Taylor RJ, Trifilieff A, Tuffnell A..  (2014)  The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist.,  24  (17): [PMID:25065493] [10.1016/j.bmcl.2014.06.014]
2. Arnold N, Beattie D, Bradley M, Brearley A, Brown L, Charlton SJ, Fairhurst RA, Farr D, Fozard J, Fullerton J, Gosling M, Hatto J, Janus D, Jones D, Jordan L, Lewis C, Maas J, McCarthy C, Mercer M, Oakman H, Press N, Profit R, Schuerch F, Sykes D, Taylor RJ, Trifilieff A, Tuffnell A..  (2014)  The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist.,  24  (17): [PMID:25065493] [10.1016/j.bmcl.2014.06.014]

Source